Dr. Neal Walker | President and Chief Executive Officer |
Dr. Stuart Shanler | Chief Scientific Officer |
Brett Fair | Senior Vice President, Commercial Operations |
Frank Ruffo | Chief Financial Officer |
Kamil Ali-Jackson | Chief Legal Officer |
Seamus Fernandez | Leerink Partners |
Brandon Folkes | Cantor Fitzgerald |
Liav Abraham | Citi |
Good day, ladies and gentlemen, and welcome to the Aclaris Therapeutics Q3 2017 Earnings Conference Call. At this time, all participants are in a listen-only-mode. Later, we will conduct the question-and-answer session and instructions will follow at that time. [Operator Instructions]. I would now turn the conference over to Kamil Ali-Jackson.